Inventor · disambiguated record
Yan Yang
Also filed as: YANG YAN · YANG YAN-OU
6 granted patents·10 pending applications·0 citations·filing 2002–2025
67Inventor score
Top patents by PatentIndex Score
16 records- 0176US12240908B2N-terminal scFv multispecific binding moleculesREGENERON PHARMA·Filed 2022·Granted Mar 4, 2025·0 cites·10 claims
- 0269US12240907B2N-terminal scFv multispecific binding moleculesREGENERON PHARMA·Filed 2020·Granted Mar 4, 2025·0 cites·18 claims
- 0368US2025171545A1N-TERMINAL scFv MULTISPECIFIC BINDING MOLECULESREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0466US2024158515A1Anti-fgfr3 antibodies and antigen-binding fragments and methods of use thereofREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0565US2024173426A1Compositions and methods for fibroblast growth factor receptor 3-mediated delivery to astrocytesREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0665US2025051432A1Methods of treating chronic graft-versus-host disease using an anti-colony stimulating factor 1 receptor antibodyINCYTE CORP·Filed 2024·Application pending·0 cites
- 0763US2024247069A1Fgfr3 binding molecules and methods of use thereofREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0862US11884734B2Anti-MET antibodies and methods of use thereofCELLDEX THERAPEUTICS INC·Filed 2020·Granted Jan 30, 2024·0 cites·16 claims
- 0958US8012927B2Platelet promoting protein and the usage thereofXU PEILIN·Filed 2009·Granted Sep 6, 2011·0 cites·5 claims
- 1048US2007178559A1Platelet promoting protein and the usage thereofXU PEILIN·Filed 2007·Application pending·0 cites
- 1148US2018057595A1Anti-MET Antibodies and Methods of Use ThereofCELLDEX THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1246US2004115184A1Methods and compositions for modifying apolipoprotein b mrna editingFiled 2002·Application pending·0 cites
- 1342US2010297219A1Methods and Compositions for Modifying Apolipoprotein B mRNA EditingUNIV ROCHESTER MEDICAL CT·Filed 2010·Application pending·0 cites
- 1438US10738112B2Anti-human interleukin-17A monoclonal antibodySUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO LTD·Filed 2017·Granted Aug 11, 2020·0 cites·13 claims
- 1537US9273134B2Inhibitors of receptor tyrosine kinases and methods of use thereofSCHLESSINGER JOSEPH·Filed 2008·Granted Mar 1, 2016·0 cites·9 claims
- 1631US2013071397A1Inhibitors of vascular endothelial growth factor (vegf) receptors and methods of use thereofSCHLESSINGER JOSEPH·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yan Yang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →